Cargando…

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

ER content of primary tumour tissue has been examined in 704 patients presenting with operable breast cancer. The median follow-up is now 84 months and no patient has received adjuvant therapy of any kind. ER status is related to histological grade, menopausal status, initial site of metastases and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, M. R., Todd, J. H., Ellis, I. O., Dowle, C. S., Haybittle, J. L., Elston, C. W., Nicholson, R. I., Griffiths, K., Blamey, R. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001565/ https://www.ncbi.nlm.nih.gov/pubmed/3814477

Ejemplares similares

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Oestrogen-receptor status and sites of metastasis in breast cancer.
por: Campbell, F. C., et al.
Publicado: (1981)

Confirmation of a prognostic index in primary breast cancer.
por: Todd, J. H., et al.
Publicado: (1987)

Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer.
por: Mumford, C. J., et al.
Publicado: (1983)

A prognostic index in primary breast cancer.
por: Haybittle, J. L., et al.
Publicado: (1982)

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.
por: Maynard, P. V., et al.
Publicado: (1978)

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
por: Robertson, J. F., et al.
Publicado: (1992)

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
por: Poller, D. N., et al.
Publicado: (1992)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
por: Lovekin, C., et al.
Publicado: (1991)

Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
por: Ellis, I. O., et al.
Publicado: (1987)

Ki67 immunostaining in primary breast cancer: pathological and clinical associations.
por: Bouzubar, N., et al.
Publicado: (1989)

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.
por: Owainati, A. A., et al.
Publicado: (1987)

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
por: McClelland, R. A., et al.
Publicado: (1998)

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
por: Poller, D. N., et al.
Publicado: (1993)

P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
por: Dixon, A. R., et al.
Publicado: (1992)

c-myc oncogene product expression and prognosis in operable breast cancer.
por: Locker, A. P., et al.
Publicado: (1989)

A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
por: Dixon, A. R., et al.
Publicado: (1992)

Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.
por: du Toit, R. S., et al.
Publicado: (1989)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

CERN Developments for 704 MHz Superconducting Cavities
por: Capatina, O, et al.
Publicado: (2013)

Early-onset breast cancer--histopathological and prognostic considerations.
por: Kollias, J., et al.
Publicado: (1997)

Memorandum: R704 status
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1983)

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
por: Williams, M. R., et al.
Publicado: (1986)

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.
por: Howell, A., et al.
Publicado: (1996)

The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
por: Winstanley, J., et al.
Publicado: (1991)

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.
por: Pinder, S. E., et al.
Publicado: (1995)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
por: Osborne, C K, et al.
Publicado: (2004)

Essais prevus sur le prototype T704
por: Guillet, J, et al.
Publicado: (1975)

Memorandum: layout for R704 experiment
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1981)

Planning of R704 during 1983
por: Macri, M
Publicado: (1982)

Spin physics at E-704 and RHIC
por: Underwood, D G
Publicado: (1996)

delivery of the 704 MHz HIPPI Cavity
por: Bosland, P, et al.
Publicado: (2007)

704 Overhead travelling crane transport
por: Sylvie Prodon
Publicado: (2004)

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
por: Travis, A., et al.
Publicado: (1996)

Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
por: Henry, J. A., et al.
Publicado: (1990)

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
por: Archer, S. G., et al.
Publicado: (1995)

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
por: Borley, Annabel C, et al.
Publicado: (2008)

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
por: Dixon, A. R., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_9sa8a26np211fb2tc9fcu30q1d